By Josh White
Date: Wednesday 02 Jul 2025
(Sharecast News) - Celadon Pharmaceuticals announced on Wednesday that it intends to delist its shares from AIM and re-register as a private limited company, subject to shareholder approval.
By Josh White
Date: Wednesday 30 Apr 2025
(Sharecast News) - Celadon Pharmaceuticals reiterated on Wednesday that it has yet to receive funds under its secured credit facility, and was still facing significant funding uncertainty, raising the prospect of administration if additional financing is not secured promptly.
By Josh White
Date: Friday 31 Jan 2025
(Sharecast News) - Celadon Pharmaceuticals reported on Friday that it has received £0.897m of a £1m drawdown request from its committed credit facility, with the remaining £0.1m now expected in February.
Currency | UK Pounds |
Share Price | 13.40p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 77.50 |
52 Week Low | 3.00 |
Volume | 0 |
Shares Issued | 68.85m |
Market Cap | £9.23m |
RiskGrade | 111 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
You are here: research